查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1379125

2023-2028 年按产品、技术、测试类型和地区分類的新生儿筛检市场报告

Newborn Screening Market Report by Product, Technology, Test Type, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球新生儿筛检市场规模达到9.56亿美元。展望未来， IMARC Group预计到2028年市场规模将达到14.67亿美元，2022-2028年复合年增长率（CAGR）为7.4%。人们对各种严重疾病的早期疾病检测的认识不断增强、政府的有利倡议以及医疗技术的创新以实现更准确的结果和疾病检测的效率是推动市场的一些主要因素。

新生儿筛检是一项重要的公共卫生方法，旨在确定婴儿出生后不久的某些健康状况。它是透过从婴儿脚后跟抽取几滴血来进行的。它甚至可以在症状出现之前及早发现潜在的严重状况。它有助于评估各种先天性疾病、代谢异常和遗传疾病。除此之外，它还使医疗保健专业人员能够透过预防或尽量减少这些情况的影响来及时采取干预和治疗措施。

目前，儿童对提高生活品质的需求不断增长，支撑着市场的成长。除此之外，遗传和代谢疾病的日益流行，以及全球出生率的上升，正在加强市场的成长。此外，对可改善结果并降低医疗成本的筛检测试的需求不断增长，正在对市场产生积极影响。除此之外，资料管理和分析工具的日益整合以提高新生儿筛检的效率，为行业投资者提供了利润丰厚的成长机会。此外，父母对整体健康和预防性医疗保健措施的日益关注正在推动市场的成长。与此一致，自动化和数位化在医疗保健领域的日益普及正在推动市场的成长。

新生儿筛检市场趋势/驱动因素：

对早期疾病检测的认识不断提高

父母对早期疾病检测的重要性的认识不断提高，这有助于市场的成长。据此，早期疾病检测有助于及时介入、改善治疗结果并改善儿童的生活品质。它也有助于保障个人健康和福祉。除此之外，它还可以避免潜在的併发症，减轻医疗保健系统的负担，并提高整体生活品质。此外，对提供早期疾病检测的先进筛检技术和医疗保健服务的需求不断增长，也推动了市场的成长。

有利的政府倡议

各国管理机构正在鼓励采用新生儿筛检来预防和管理世界各地的健康状况，这提供了积极的市场前景。此外，他们正在实施强制性新生儿筛检计划，这使得更多人口更容易获得这些服务。他们也采取倡议，通常涵盖一系列全面的疾病，并确保有效解决各种潜在的健康问题。此外，他们正在组织教育活动，向医疗保健提供者传播知识，为人们提供指导。

因此，这些措施有助于提高大众对全球早期发现疾病的好处的认识。

医疗科技创新

各个製造商正在迅速推进其医疗技术，以增强新生儿筛检方法。此外，串联质谱 (MS) 和脱氧核糖核酸 (DNA) 检测等创新技术有助于提高疾病检测的准确性和效率。这些技术能够同时筛检更广泛的疾病，增强诊断能力，甚至可以及早辨识罕见疾病。除此之外，这些筛检技术的出现鼓励医疗保健提供者采用和提供这些服务。此外，科技的进步可以最大限度地减少侵入性、缩短恢復时间并提高患者的舒适度，同时提高医疗干预的速度。

新生儿筛检产业细分：

IMARC Group提供了全球新生儿筛检市场报告各细分市场主要趋势的分析，以及 2023 年至 2028 年全球、区域和国家层面的预测。我们的报告根据产品、技术和测试类型对市场进行了分类。

按产品划分：

仪器

试剂

仪器代表最大的细分市场

该报告根据产品提供了详细的市场细分和分析。这包括仪器和试剂。报告称，仪器仪表占最大部分。仪器为样本采集、分析和结果解释提供必要的工具，在筛选过程中发挥重要作用。这些设备包含多种技术，例如质谱系统、脱氧核糖核酸 (DNA) 分析仪和自动筛选平台。这些仪器旨在确保筛检程序的准确性、效率和可重复性。它们使医疗保健专业人员能够精确处理大量样本，并促进各种疾病的早期检测。此外，对可靠且用户友好的仪器的需求不断增长正在支持市场的成长。

按技术划分：

串联质谱法

脉搏血氧仪

基于酵素的测定

DNA检测

电泳

其他的

串联质谱占据大部分市场份额

该报告基于该技术对市场进行了详细的细分和分析。这包括串联质谱法、脉搏血氧测定法、酵素测定法、DNA 测定法、电泳法等。根据该报告，串联质谱法代表了最大的部分。串联质谱是一种分析技术，用于新生儿筛检，以识别一系列代谢紊乱。它涉及质谱分析的两个阶段，其中离子被破碎并分析以精确识别化合物。除此之外，它还提供了更高的准确性和速度，并且可以检测罕见的疾病。与此一致的是，医学领域的技术进步提高了串联质谱的敏感度和特异性，从而改善了全世界婴儿的健康结果。

按测试类型划分：

干血斑测试

慢性心臟衰竭

听力筛检

干血斑占最大市场份额

该报告根据测试类型提供了详细的市场细分和分析。这包括干血斑测试、CCHD 和听力筛检。报告称，干血斑测试占最大部分。干血斑测试是一种非侵入性且广泛使用的筛检技术，涉及从新生儿脚跟收集少量血液到特殊的滤纸上。然后分析干燥的血液样本中是否存在与各种疾病相关的特定标记。除此之外，它还可以及早发现先天性甲状腺功能低下症和镰状细胞疾病等疾病。此外，许多新生儿筛检计画越来越青睐干血斑检测，因为干血斑检测提供了样本采集的便利性、运输的便利性以及同时筛检多种疾病的能力，这也促进了市场的增长。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美表现出明显的主导地位，占据最大的新生儿筛检市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据最大的市场份额。

由于先进的医疗基础设施，北美占据了最大的市场份额。此外，个人对新生儿筛检的长期好处的认识不断提高，正在加强该地区市场的成长。除此之外，有利的政府措施和法规也带来了积极的市场前景。与此一致的是，对预防性医疗保健的日益关注正在支持北美地区市场的成长。

竞争格局：

各製造商正在投资研发 (R&D) 活动，以提供创新的筛选技术和方法。这包括改进串联质谱等现有技术，并探索新方法来扩大检测条件的范围。此外，公司还透过在测试组中添加更多条件来提供更全面的筛选服务。除此之外，主要参与者正在专注于开发自动化系统，以简化从样本收集到结果解释的筛选过程，以提高效率、减少人为错误并缩短週转时间。此外，公司还专注于资料管理解决方案，以确保准确的记录保存、轻鬆存取结果以及与电子健康记录的资料整合。

该报告对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

安捷伦科技公司

宝贝公司

Bio-RAD 实验室公司

Chromsystems 仪器与化学品有限公司

丹纳赫公司

马西莫公司

美敦力公司

内特斯医疗公司

珀金内尔默公司

RECIPE 化学品+仪器有限公司

赛默飞世尔科技公司

Trivitron 医疗保健

沃特世公司

最近的发展：

2022 年8 月，Trivitron Healthcare 在印度维沙卡帕特南AMTZ 园区开设了其卓越中心，拥有最先进的研发(R&D) 和製造设施，用于代谢组学、基因组学、新生儿筛检和分子诊断。

2020 年 11 月，领先的医疗设备解决方案提供商 Natus Medical Inc. 收购了德国医疗设备公司 Babybe GmbH 及其专利的远距母婴通讯技术。 Babybe 技术已被添加到 Natus 市场领先的新生儿护理产品组合中。

2022 年11 月，PerkinElmer Inc. 宣布美国食品药物管理局(FDA) 已授权销售EONIS (TM) SCID-SMA 检测试剂盒，供经过认证的实验室用于体外诊断(IVD)，用于同时检测脊椎新生儿肌肉萎缩症（SMA）和严重复合型免疫缺陷症（SCID）。

本报告回答的关键问题

  • 2022年全球新生儿筛检市场规模有多大
  • 2023-2028年全球新生儿筛检市场的预期成长率是多少
  • 推动全球新生儿筛检市场的关键因素是什么
  • COVID-19 对全球新生儿筛检市场有何影响
  • 基于产品的全球新生儿筛检市场区隔是怎样的
  • 基于该技术的全球新生儿筛检市场的细分如何
  • 根据测试类型，全球新生儿筛检市场的细分如何
  • 全球新生儿筛检市场的重点区域有哪些
  • 谁是全球新生儿筛检市场的主要参与者/公司

本报告回答的关键问题

  • 2022年全球新生儿筛检市场规模有多大？
  • 2023-2028年全球新生儿筛检市场的预期成长率是多少？
  • 推动全球新生儿筛检市场的关键因素是什么？
  • COVID-19 对全球新生儿筛检市场有何影响？
  • 基于产品的全球新生儿筛检市场的细分如何？
  • 基于该技术的全球新生儿筛检市场的细分情况如何？
  • 根据测试类型，全球新生儿筛检市场的细分如何？
  • 全球新生儿筛检市场的重点区域有哪些？
  • 全球新生儿筛检市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球新生儿筛检市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 仪器
    • 市场走向
    • 市场预测
  • 试剂
    • 市场走向
    • 市场预测

第 7 章：依科技分類的市场

  • 串联质谱法
    • 市场走向
    • 市场预测
  • 脉搏血氧仪
    • 市场走向
    • 市场预测
  • 基于酵素的测定
    • 市场走向
    • 市场预测
  • DNA检测
    • 市场走向
    • 市场预测
  • 电泳
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按测试类型分類的市场

  • 干血斑测试
    • 市场走向
    • 市场预测
  • 慢性心臟衰竭
    • 市场走向
    • 市场预测
  • 听力筛检
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Baebies Inc.
    • Bio-RAD Laboratories Inc.
    • Chromsystems Instruments & Chemicals GmbH
    • Danaher Corporation
    • Masimo Corporation
    • Medtronic plc
    • Natus Medical Incorporated
    • Perkinelmer Inc.
    • RECIPE Chemicals + Instruments GmbH
    • Thermo Fisher Scientific Inc.
    • Trivitron Healthcare
    • Waters Corporation
Product Code: SR112023A4068

Abstract

The global newborn screening market size reached US$ 956 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,467 Million by 2028, exhibiting a growth rate (CAGR) of 7.4% during 2022-2028. The growing awareness about early disease detection of various severe diseases, favorable government initiatives, and innovations in medical technology for more accurate outcomes and efficiency of disease detection are some of the major factors propelling the market.

Newborn screening is a vital public health approach that is designed to identify certain health conditions in infants shortly after birth. It is performed through a few drops of blood taken from the heel of the baby. It allows for the early detection of potentially serious conditions, even before symptoms appear. It assists in assessing a wide range of congenital disorders, metabolic irregularities, and genetic diseases. Besides this, it enables healthcare professionals to initiate timely interventions and treatments by preventing or minimizing the impact of these conditions.

At present, the rising demand for enhanced quality of life among children is supporting the growth of the market. Besides this, the increasing prevalence of genetic and metabolic disorders, along with rising birth rates across the globe, is strengthening the growth of the market. Additionally, the growing demand for screening tests that offer improved outcomes and reduced healthcare costs is positively influencing the market. Apart from this, the increasing integration of data management and analysis tools to enhance the efficiency of newborn screening is offering lucrative growth opportunities to industry investors. Furthermore, the rising focus on holistic well-being and preventive healthcare measures among parents is bolstering the growth of the market. In line with this, the increasing popularity of automation and digitalization in the healthcare sector is propelling the growth of the market.

Newborn Screening Market Trends/Drivers:

Rising awareness about early disease detection

The rising awareness among parents about the critical importance of early disease detection is contributing to the growth of the market. In line with this, early disease detection assists in offering timely intervention, improved treatment outcomes, and enhanced quality of life for the child. It also aids in safeguarding individual health and well-being. Apart from this, it can avoid potential complications, reduce the burden on healthcare systems, and improve the overall quality of life. Furthermore, the increasing demand for advanced screening technologies and healthcare services that offer early disease detection is bolstering the growth of the market.

Favorable government initiatives

Governing agencies of various countries are encouraging the adoption of newborn screening to prevent and manage health conditions around the world, which is offering a positive market outlook. In addition, they are implementing mandatory newborn screening programs, which makes these services more accessible to a larger population. They are also taking initiatives that often cover a comprehensive panel of disorders and ensure that a wide range of potential health issues are addressed efficiently. Furthermore, they are organizing educational campaigns to spread knowledge among healthcare providers to provide guidance to people.

As a result, these initiatives benefit in generating awareness among the masses about the benefits of early detection of diseases across the globe.

Innovations in medical technology

Various manufacturers are rapidly advancing their medical technologies to enhance newborn screening methods. In addition, innovative techniques, such as tandem mass spectrometry (MS) and deoxyribonucleic acid (DNA)-based testing, assist in increasing the accuracy and efficiency of disease detection. These technologies enable the simultaneous screening of a broader range of disorders, enhance diagnostic capabilities, and allow for early identification of even rare conditions. Apart from this, the emergence of these screening technologies encourages healthcare providers to adopt and offer these services. Furthermore, advancements in technologies minimize invasiveness, reduce recovery times, and improve patient comfort while enhancing the speed of medical interventions.

Newborn Screening Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global newborn screening market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product, technology and test type.

Breakup by Product:

Instruments

Reagents

Instruments represents the largest market segment

The report has provided a detailed breakup and analysis of the market based on the product. This includes instruments and reagents. According to the report, instruments represented the largest segment. Instruments play an important role in the screening process by providing the necessary tools for sample collection, analysis, and result interpretation. These devices comprise a diverse range of technologies, such as mass spectrometry systems, deoxyribonucleic acid (DNA) analyzers, and automated screening platforms. These instruments are designed to ensure accuracy, efficiency, and reproducibility in the screening procedures. They enable healthcare professionals to process a high volume of samples with precision and facilitate the early detection of various disorders. Furthermore, the rising demand for reliable and user-friendly instruments is supporting the growth of the market.

Breakup by Technology:

Tandem Mass Spectrometry

Pulse Oximetry

Enzyme Based Assay

DNA Assay

Electrophoresis

Others

Tandem mass spectrometry accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the technology. This includes tandem mass spectrometry, pulse oximetry, enzyme based assay, DNA assay, electrophoresis, and others. According to the report, tandem mass spectrometry represented the largest segment. Tandem mass spectrometry is an analytical technique that is employed in newborn screening to identify a range of metabolic disorders. It involves two stages of mass spectrometry, where ions are fragmented and analyzed for precise identification of compounds. Apart from this, it offers enhanced accuracy and speed and can detect rare disorders. In line with this, technological advancements in the medical field enhance the sensitivity and specificity of tandem mass spectrometry that offers improved health outcomes for infants worldwide.

Breakup by Test Type:

Dry Blood Spot Test

CCHD

Hearing Screen

Dry blood spot holds the biggest market share

The report has provided a detailed breakup and analysis of the market based on the test type. This includes dry blood spot test, CCHD, and hearing screen. According to the report, dry blood spot test represented the largest segment. A dry blood spot test is a non-invasive and widely utilized screening technique that involves collecting a small amount of blood from the heel of a newborn onto a special filter paper. This dried blood sample is then analyzed for the presence of specific markers associated with various disorders. Apart from this, it enables early detection of conditions, such as congenital hypothyroidism and sickle cell disease. Moreover, the rising preference for dry blood spot tests in many newborn screening programs, as they offer the convenience of sample collection, ease of transportation, and the ability to simultaneously screen for multiple conditions, is bolstering the growth of the market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest newborn screening market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the presence of advanced healthcare infrastructure. In addition, the rising awareness about the long-term benefits of newborn screening among individuals is strengthening the growth of the market in the region. Apart from this, favorable government initiatives and regulations are offering a positive market outlook. In line with this, the increasing focus on preventive healthcare is supporting the growth of the market in the North America region.

Competitive Landscape:

Various manufacturers are investing in research and development (R&D) activities to provide innovative screening technologies and methods. This includes refining existing techniques like tandem mass spectrometry and exploring new approaches to broaden the scope of conditions detected. In addition, companies are providing a more comprehensive screening service by adding more conditions to their test panels. Apart from this, key players are focusing on developing automated systems that streamline the screening process, from sample collection to result interpretation, to enhance efficiency, reduce human error, and allow for faster turnaround times. Furthermore, companies are focusing on data management solutions to ensure accurate record-keeping, easy access to results, and data integration with electronic health records.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Baebies Inc.

Bio-RAD Laboratories Inc.

Chromsystems Instruments & Chemicals GmbH

Danaher Corporation

Masimo Corporation

Medtronic plc

Natus Medical Incorporated

Perkinelmer Inc.

RECIPE Chemicals + Instruments GmbH

Thermo Fisher Scientific Inc.

Trivitron Healthcare

Waters Corporation

Recent Developments:

In August 2022, Trivitron Healthcare inaugurated its centre-of-excellence with state-of-the-art research and development (R&D) and manufacturing facilities at AMTZ Campus, Vishakhapatnam, India for metabolomics, genomics, newborn screening, and molecular diagnostics.

In November 2020, Natus Medical Inc., a leading provider of medical device solutions, acquired German healthcare equipment company Babybe GmbH and its patented remote mother to baby communication technology. The Babybe technology has been added to Natus's market leading Newborn Care portfolio of products.

In November 2022, PerkinElmer Inc. announced that the U.S. Food and Drug Administration (FDA) has authorized the marketing of the EONIS™ SCID-SMA assay kit for in vitro diagnostic (IVD) use by certified laboratories for the simultaneous detection of spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns.

Key Questions Answered in This Report

  • 1. What was the size of the global newborn screening market in 2022?
  • 2. What is the expected growth rate of the global newborn screening market during 2023-2028?
  • 3. What are the key factors driving the global newborn screening market?
  • 4. What has been the impact of COVID-19 on the global newborn screening market?
  • 5. What is the breakup of the global newborn screening market based on the product?
  • 6. What is the breakup of the global newborn screening market based on the technology?
  • 7. What is the breakup of the global newborn screening market based on the test type?
  • 8. What are the key regions in the global newborn screening market?
  • 9. Who are the key players/companies in the global newborn screening market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Newborn Screening Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Tandem Mass Spectrometry
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pulse Oximetry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Enzyme Based Assay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 DNA Assay
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Electrophoresis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Test Type

  • 8.1 Dry Blood Spot Test
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 CCHD
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hearing Screen
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Baebies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Chromsystems Instruments & Chemicals GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Masimo Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Natus Medical Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Perkinelmer Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 RECIPE Chemicals + Instruments GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Trivitron Healthcare
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Waters Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Newborn Screening Market: Major Drivers and Challenges
  • Figure 2: Global: Newborn Screening Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Newborn Screening Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Newborn Screening Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Newborn Screening Market: Breakup by Test Type (in %), 2022
  • Figure 7: Global: Newborn Screening Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Newborn Screening (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Newborn Screening (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Newborn Screening (Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Newborn Screening (Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Newborn Screening (Tandem Mass Spectrometry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Newborn Screening (Tandem Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Newborn Screening (Pulse Oximetry) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Newborn Screening (Pulse Oximetry) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Newborn Screening (Enzyme Based Assay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Newborn Screening (Enzyme Based Assay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Newborn Screening (DNA Assay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Newborn Screening (DNA Assay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Newborn Screening (Electrophoresis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Newborn Screening (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Newborn Screening (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Newborn Screening (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Newborn Screening (Dry Blood Spot Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Newborn Screening (Dry Blood Spot Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Newborn Screening (CCHD) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Newborn Screening (CCHD) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Newborn Screening (Hearing Screen) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Newborn Screening (Hearing Screen) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Newborn Screening Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Newborn Screening Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Newborn Screening Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Newborn Screening Industry: SWOT Analysis
  • Figure 80: Global: Newborn Screening Industry: Value Chain Analysis
  • Figure 81: Global: Newborn Screening Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Newborn Screening Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Newborn Screening Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Newborn Screening Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Newborn Screening Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 5: Global: Newborn Screening Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Newborn Screening Market: Competitive Structure
  • Table 7: Global: Newborn Screening Market: Key Players